Sector portfolio · VC firm · United States

ARCH Venture Partners' Biotech portfolio

ARCH Venture Partners has backed 104 Biotech startups in rounds we track, $15B between them, shown by the stage each has reached. The best-funded is Grail.

104startups backed
5stages
$15Braised between them
Series Abiggest stage

ARCH Venture Partners's whole portfolioARCH Venture Partners's profile

Series A

30

+6 more

Series B

29

+5 more

Stage not reported

22

Series C and later

21

Pre-seed and seed

2

Segment by segment

Series A

30 startups · $2.9B raised

  1. ErascaErasca is a developer of oncology drugs intended to provide precision oncology options.United States$739M
  2. Dispatch BioDispatch Bio is a biotechnology company founded in 2022, focused on developing a universal treatment for solid tumors.United States$216M
  3. Tome BiosciencesTome Biosciences is a biotechnology company based in Watertown, MA, focused on advancing programmable genomic integration (PGI) toUnited States$213M
  4. Verve TherapeuticsVerve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.United States$202M
  5. Treeline BiosciencesTreeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.United States$200M
  6. Tenvie TherapeuticsTenvie Therapeutics, Inc.United States$200M
  7. Bitterroot BioBitterroot Bio, Inc.United States$145M
  8. Paratus SciencesParatus Sciences is a biotechnology startup founded in 2021, based in New York, NY, with a subsidiary in Singapore.United States$100M

Series B

29 startups · $5.9B raised

  1. GGrailUnited States$1.6B
  2. Gossamer BioGossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.United States$567M
  3. Denali TherapeuticsDenali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.United States$547M
  4. Beam TherapeuticsBeam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.United States$322M
  5. Mirador TherapeuticsMirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California.United States$250M
  6. CTCity TherapeuticsUnited States$235M
  7. CREATE MedicinesCREATE Medicines is a clinical-stage biotechnology company based in Cambridge, Massachusetts.United States$195M
  8. Hua MedicineHua Medicine is a clinical-stage, innovative drug development company in China.China$192M

Stage not reported

22 startups · $2.4B raised

  1. EQRxEQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.United States$1.2B
  2. Rapport TherapeuticsRapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.United States$250M
  3. bluebird biobluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days.United States$151M
  4. Vir BiotechnologyVir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.United States$150M
  5. BIND TherapeuticsBIND Therapeutics is a biotechnology company incorporated in 2006; Pfizer acquired substantially all of its assets in 2016.United States$138M
  6. Lyell ImmunopharmaLyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.United States$100M
  7. NNeurogesXNeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.United States$92M
  8. Sana BiotechnologySana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.United States$69M

Series C and later

21 startups · $3.6B raised

  1. ArsenalBioArsenalBio is a programmable cell therapy company that offers advanced CAR T-cell therapies for solid tumors.United States$410M
  2. Encoded TherapeuticsEncoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.United States$379M
  3. EeGenesisUnited States$329M
  4. bit.biobit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom.United Kingdom$264M
  5. LifeMine TherapeuticsLifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.United States$230M
  6. Dewpoint TherapeuticsDewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.United States$196M
  7. Vividion TherapeuticsWe are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with dUnited States$185M
  8. MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M

Pre-seed and seed

2 startups · $18M raised

  1. UBUltraDx BioUltraDx Bio is a biotechnology company that specializes in single-molecule digital high-sensitivity protein detection technology.China$14M
  2. Nebula GenomicsNebula Genomics is a personal genomics company based in San Francisco, California, founded in 2016 by Dr.United States$4.3M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names ARCH Venture Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioARCH Venture Partners' Pharma portfolio15 startups · $6.5BPortfolio mapARCH Venture Partners portfolio map143 startups · $36BCo-investorsWho invests with ARCH Venture Partners132 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426B

Raising from investors like ARCH Venture Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps